BCIwiki — Brain-computer interface news, research and industry database

Guangdong Provincial Hospital of Traditional Chinese Medicine has registered a parallel-design interventional trial, ChiCTR2600124411, that plans to enroll 81 patients with unilateral upper-limb impairment after stroke in three groups of 27. Two groups receive intermittent theta-burst stimulation (iTBS) over the dorsolateral prefrontal cortex or the primary motor cortex, and one receives sham stimulation; all three undergo motor imagery BCI training. Primary outcomes are BCI decoding accuracy, the Fugl-Meyer Assessment and brain network topology. The trial was registered on May 12, 2026 and is not yet recruiting.

The trial plans to enroll 40 patients with Parkinson's disease aged 40 to 80, randomized into 2 groups: one adds brain-computer interface rehabilitation training to functional electrical stimulation, the other receives functional electrical stimulation alone. Both arms train 20 minutes per day for the upper extremities and 20 minutes per day for the lower extremities, completing 12 treatment days within 2 weeks. The primary endpoint is a motor symptom rating scale, with diffusion tensor imaging, magnetic resonance spectroscopy, resting-state fMRI, and sleep, cognitive and mood scales as secondary endpoints, testing whether adding BCI training produces measurable change beyond motor symptoms.

A trial at Xuzhou Rehabilitation Hospital Affiliated to Xuzhou Medical University paired a motor imagery brain-computer interface with modified constraint-induced movement therapy to restore upper-limb function after stroke. The hospital is a rehabilitation specialty facility affiliated with Xuzhou Medical University, and the combined approach is meant to test whether a BCI adds benefit on top of established rehabilitation training. It planned 40 participants, 20 in the combined group and 20 in the control group, with the first patient enrolled on December 24, 2025; the registry now lists the study as completed. The primary endpoint is the Fugl-Meyer Assessment for Upper Extremity, with the Wolf Motor Function Test and modified Barthel Index as secondary measures. Funding comes from the New Round of Xuzhou "Pengcheng Talent Program" — High-level Healthcare Talent Recruitment and Development Project, project number 2025TD14. No results are posted, so whether the combined approach beats constraint therapy alone remains unknown.

A trial testing a brain-computer interface (BCI) combined with transcranial direct current stimulation (tDCS) in patients with disorders of consciousness was registered with the Chinese Clinical Trial Registry (ChiCTR) on May 7, 2026 under the number ChiCTR2600124127, and is now recruiting. The design, sample size and sponsor are not given in the record and would have to be checked against the original registration.

A randomized, sham-controlled trial will pair a non-invasive brain-computer interface with MRI-guided multichannel temporal interference stimulation in patients whose migraines resist medication. It plans to enroll 78 people aged 18 to 65, split evenly between real and sham stimulation, with headache frequency as the primary endpoint. The registration lists only design and bibliographic fields, so device details and actual enrollment remain unknown and efficacy has yet to be read out.

Researchers assessed the feasibility of a hybrid brain-computer interface that integrates motor imagery (MI) and steady-state visual evoked potentials (SSVEP) with robotic glove feedback for upper limb motor rehabilitation in 32 stroke patients, split into a conventional-treatment control group and an experimental group receiving 10- or 20-day BCI interventions. The experimental group showed considerable improvement in Fugl-Meyer scores over the control group, and the BCI achieved EEG classification accuracy up to 98.08% with stable operation; after longer training, accuracy rose, the laterality coefficient moved toward normal, and task-related brain connectivity strengthened. The authors say the hybrid system may overcome the limits of conventional therapy and single-modality BCIs.

The Chinese Clinical Trial Registry (ChiCTR) has logged a study of the safety and efficacy of early brain-computer interface training given after reperfusion therapy in patients with acute ischemic stroke, an attempt to pin down when in the recovery window such training should start. Registered on April 27, 2026 as ChiCTR2600123548, the trial has not begun recruiting, and design, sample size and sponsor are absent from the record carried by the WHO International Clinical Trials Registry Platform (ICTRP) and must be read from the original registration.

The Chinese Clinical Trial Registry (ChiCTR) has logged a multicenter randomized controlled trial testing whether brain-computer interface-based mindfulness meditation relieves the symptoms of chronic tinnitus. Registered on April 23, 2026 as ChiCTR2600123258, the trial has not begun enrolling patients, and its design, sample size and sponsor must be read from the original registration record. It is the first multicenter registration to combine BCI with mindfulness meditation for chronic tinnitus, moving the approach from single-center exploration toward multicenter validation.

A trial registered with the Chinese Clinical Trial Registry combines low-frequency rTMS with motor imagery brain-computer interface therapy, using conventional physical rehabilitation as the control, with the Fugl-Meyer upper extremity scale as the primary endpoint. The study has three parts: Part I compares BCI therapy with conventional rehabilitation, while Part III compares three rTMS protocols. It plans to enroll 213 participants, with first enrolment set for May 1, 2026; recruitment has not yet begun.